Soon, the Tata Memorial Centre will serve about two lakh new cancer patients each year, and recent studies by the prestigious hospital have shown that practicing yoga and receiving two inexpensive injections might prolong patients' lives in cases of breast cancer.
The Tata Memorial Centre (TMC) is the biggest and oldest cancer center in India, treating 1.25 lakh new cancer patients each year at its eight locations throughout the nation. Mumbai alone sees 80,000 new patients each year and conducts more than 6.5 lakh follow-ups.
“It is expected that the TMC will soon treat close to two lakh new patients with cancer annually, which will account for approximately 12% to 15% of all patients diagnosed with cancer in the country every year,” the central government wrote in a note to the parliamentary committee that News18 examined.
The memo said that three experiments were done by the TMC and that they could be “implemented immediately” in India. According to the official statement, “the first study on yoga in breast cancer revealed improvement in quality of life, compliance with treatment, and a 15% decrease in mortality due to breast cancer.” Yoga was added to conventional surgery, radiation, and chemotherapy.
The yoga program was applied in courses by certified and experienced teachers, and it comprised soft, restorative poses with frequent relaxation and pranayama breaks.
“The other two studies tested two inexpensive injection-based therapies that resulted in a 29% and 26% survival rate for breast cancer patients. Both of these injections are accessible across India as a part of state insurance programs and the Arogyasri program. The message adds that these injections would only set you back Rs 25 and Rs 2,000.
NEED FOR MORE EXCELLENCE CENTRES
The Tata Memorial Hospital (TMH) and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Mumbai are two examples of centers of excellence for cancer treatment that the country needs more of. In response, the TMC has started a major expansion plan that will quadruple its patient care capabilities and increase its geographic presence. Six hospitals in Varanasi, Guwahati, Sangrur, Visakhapatnam, Chandigarh, and Muzaffarpur are now part of the TMC, which began in Mumbai.
The TMC began with 840 beds in 2017 and expanded to 2,200 beds in 2022. It will then continue to develop, reaching 2,800 beds by the end of 2023 and 3,400 beds by the end of 2026. Nowadays, it handles over 1.25 lakh new cancer patients each year, or about 10% of the total number of cancer cases in India. The ACTREC now has 500 beds and will increase to 900 beds by the end of 2023 from its initial 100 beds in 2020.
The TMC has successfully implemented the hub and spoke model of cancer treatment in Punjab and Uttar Pradesh. Additionally, the note mentioned that a proposal for a cancer hospital in Odisha is being taken into consideration. This proposal is for the campus of the department of atomic energy's NISER (National Institute of Science Education and Research), which is in a fairly advanced stage of discussion with joint funding from the government department and Tata Trusts.
In Khopoli in Maharashtra, the TMC is also developing an integrated center for cancer treatment, research, and education that would feature a facility for medicinal plants, as well as equipment and resources for cancer research involving conventional Indian medical systems.
The statement indicated that the TMC would soon serve over 2,000 additional cancer patients each year because to the increase anticipated with the construction of these new facilities.